Live Chat

More Safety Studies Pending for Transvaginal Mesh Products

Major manufacturers of transvaginal mesh implants, a widely distributed medical product that has affected thousands of women, have notified the U.S. government’s health care agency, the Food and Drug Administration (FDA), that they plan to review both the safety of implants and the appropriateness of current and possible labels.

 

Manufacturers have come under intense pressure after thousands of women experienced adverse health affects following their transvaginal mesh operation. For many of these women, the operation was intended to address their pelvic organ prolapse (POP) or stress urinary incontinence (SUI), but instead only added pain, discomfort, and embarrassment.

 

Are you suffering from the painful after effects of your transvaginal mesh surgery? The attorneys at the law firm of Fears Nachawati know what you’ve experienced and how the law can protect your rights. For your free consultation to learn how we can help you, contact us today. Just call 1.866.545.8364 or email mn@fnlawfirm.com. We can help.

Categories
Drug Litigation

More Safety Studies Pending for Transvaginal Mesh Products